Opoku, Y. K.; Liu, Z.; Afrifa, J.; Kumi, A. K.; Liu, H.; Ghartey-Kwansah, G.; Koranteng, H.; Jiang, X.; Ren, G.; Li, D. Fibroblast Growth Factor–21 Ameliorates Hepatic Encephalopathy by Activating the STAT3-SOCS3 Pathway to Inhibit Activated Hepatic Stellate Cells. EXCLI J. 2020, 19, 567-581.